Clinical Trials and Data Science Conference

Daniel Millar, MBA

Senior Director, Strategic Business Transformation, Johnson & Johnson, United States

Cecile Spiertz, MSC

, Netherlands

Deliverables from IMI EU-PEARL and How these will be Sustained Post-Project

Jonathan Mackinnon, PHD

Associate Director, Medical Writing Services, Parexel International, Spain

Protocol Development for Master Protocol Studies – Balancing Structure with Function

Christine Fletcher, MSC

VP/Head, Speciality and Primary Care Statistics, GlaxoSmithKline, United Kingdom

Acceptance of Design and Data of Complex Innovative Design Trials by Key Decision-Makers

Olga Kholmanskikh Van Criekingen, MD, PHD

Clinical assessor, Federal Agency for Medicines and Health Products, Belgium

Panel discussion with Q&A